AMCP Annual Meeting (March 25-28, 2019)

AMCP Annual Meeting, March 25-28, 2019

Booth #808 and SIT Session March 27, 1:30-2pm, Theater #2

RxAnte will be available to discuss the latest in medication adherence solutions to help health plans looking to reduce costs and optimize their adherence strategies to achieve their operational and Star Ratings goals.

Listen in on our Science and Innovation Theater (SIT) Session on March 27 at 1:30, led by Kerri Petrin, VP of Client Services. Discover how health plans, pharmacy, and providers are collaborating in member outreach and getting more from medicines. For nearly a decade, RxAnte has been helping to create more effective outreach initiatives to improve prescribing and adherence; aligning goals among plans, providers, and pharmacies; and creating tools and technologies to support pharmacy- and provider-led interventions. Observe RxAnte programs in the field, and discover how the latest trends in population health are carving out a bigger role for pharmacy-led interventions to medically complex patients.

View the full AMCP Annual Meeting agenda here.

Related Resources

6.29.22

by Patricia Powers, PharmD

How Mosaic’s Comprehensive Pharmacy Support Enables Better Care at Home

As the Director of Clinical Services at Mosaic Pharmacy Service, Patricia Powers, Pharm.D. is responsible for overseeing the development and delivery of clinical services for all Mosaic members, RxAnte’s high-touch pharmacy service. This month we asked Dr. Powers to share her insights around at-home care coordination benefiting both the patient and the health system and how Mosaic’s comprehensive pharmacy support can help enable better care at home.

5.25.22

by Tori Erxleben Rush, PharmD

CMS Announcement for Medicare Advantage Part C and D plans

In early April, the Center for Medicaid and Medicare Services shared its Announcement for Medicare Advantage Part C and D plans, incorporating feedback solicited after an Advance Notice was issued in February 2022. Overall, not much has changed since the Advance Notice, however CMS addressed the comments issued by Medicare Advantage stakeholders like MA organizations and prescription drug plan sponsors.

4.4.22

The need for value-based pharmacy services

There is a strong push among physicians to transition to care models that incentivize fewer, more effective treatments. This same perspective should also be held in pharmacy. As we look to a post-pandemic healthcare system, improvements need to be made to remedy these concerns with focuses on barriers to optimal quality and cost--particularly for the medically complex and socially vulnerable.